top of page

Why Farbe Firma is the Top Manufacturer of Metoclopramide Injection

  • Writer: Maulik Sudani
    Maulik Sudani
  • 2 days ago
  • 6 min read

Last Updated: May 22, 2026

TL;DR: Metoclopramide Injection — metoclopramide hydrochloride, a dopamine D2-receptor antagonist that works as both an antiemetic and a gastrointestinal prokinetic, supplied as a clear sterile aqueous solution in small-volume ampoules — is the drug clinicians use to control post-operative and chemotherapy-induced nausea and vomiting and to restore gastric motility. Farbe Firma Pvt Ltd manufactures WHO-GMP certified Metoclopramide Injection at our Gujarat, India facility and supplies it to hospital tenders, distributors and brand owners in 30+ countries.

Key Takeaways

  • Drug class: Antiemetic and gastrointestinal prokinetic agent — a dopamine D2-receptor antagonist (with 5-HT3 antagonism and 5-HT4 agonism) used for post-operative and chemotherapy-induced nausea and vomiting, gastroparesis and as an aid to gastrointestinal intubation. A WHO Essential Medicine.

  • Certified manufacturing: WHO-GMP certified plant, ISO Class 5 aseptic core, validated water-for-injection loops, qualified ampoule filling lines with nitrogen purging and light-protected handling, and validated terminal moist-heat sterilisation with full container-closure integrity verification.

  • CTD-ACTD dossier support: Full eCTD and ACTD modules, ICH Q1A long-term and accelerated stability data, ICH Q1B photostability data, drug master files and CEP-style documentation for registrations across regulated and emerging markets.

  • End-to-end CMO services: Contract manufacturing, third-party manufacturing, private-label artwork, multilingual leaflets, tender-ready packaging and logistics coordination for buyers in Africa, LATAM, CIS, GCC, MENA and Southeast Asia.

Metoclopramide Injection manufacturer — Farbe Firma WHO-GMP certified sterile injectable facility, Gujarat, India
Metoclopramide Injection manufacturer — Farbe Firma's WHO-GMP certified light-protected small-volume parenteral line, Gujarat, India.

Introduction: Why Metoclopramide Injection Demands a Premium Manufacturer

Metoclopramide Injection is one of the most widely used parenteral antiemetics in hospital practice, and its value lies in doing two jobs at once. By antagonising dopamine D2 receptors in the chemoreceptor trigger zone it suppresses nausea and vomiting, and by promoting 5-HT4-mediated acetylcholine release in the gut wall it accelerates gastric emptying and coordinates upper-gastrointestinal motility. That dual action is why clinicians reach for it in post-operative nausea and vomiting, chemotherapy- and radiotherapy-induced nausea, diabetic gastroparesis, migraine-associated vomiting, and to facilitate small-bowel intubation and contrast radiology.

That broad clinical role places real demands on the manufacturer. Metoclopramide Injection is supplied as a clear, colourless aqueous solution — typically metoclopramide hydrochloride 5 mg/mL, presented as 10 mg in a 2 mL ampoule for intravenous or intramuscular use — and the molecule is sensitive to light. Photodegradation can discolour the solution and erode potency, so the product must be processed under light-protected conditions and packaged to shield it from filling through to the patient. The active is also susceptible to oxidative degradation, which means dissolved-oxygen control and a carefully held acidic pH. Choosing a Metoclopramide Injection manufacturer that treats light protection, oxidation control and pH stability as core engineering disciplines — not afterthoughts — is what keeps a high-volume hospital supply chain dependable.

What Sets a World-Class Metoclopramide Injection Manufacturer Apart

A world-class manufacturer of Metoclopramide Injection invests in three areas competitors often underinvest in: light-protected processing, oxidation-controlled formulation, and a stability programme that mirrors real-world distribution. Light-protected processing goes beyond storing finished cartons in the dark — it means shielding the bulk solution and the filling line from full-spectrum light, using actinic or amber primary containers where the specification calls for it, validating that the chosen ampoule and carton system blocks the wavelengths that drive photodegradation, and confirming through forced-degradation studies that the product survives realistic light exposure during transit and ward storage.

Oxidation-controlled formulation matters because metoclopramide degrades in the presence of dissolved oxygen. World-class plants prepare the bulk solution under nitrogen blanket, fill ampoules with a controlled low-oxygen headspace, hold pH within the acidic band where the molecule is most stable, and verify each of these parameters in-process rather than relying on the end test alone. All of this is documented cleanly for audit, supported by electronic batch records that lock deviations the moment they occur, and reinforced by 100% ampoule leak and integrity inspection and validated terminal moist-heat sterilisation from filling through final packaging.

Quality Systems Behind Every Metoclopramide Injection

Every Farbe Firma Metoclopramide Injection batch is released only after a full stack of quality checks: identity and assay by validated stability-indicating HPLC against USP, BP, IP or EP reference standards, related-substances profiling to keep oxidative and photodegradation products within monograph limits, pH, solution colour and clarity, particulate matter, bacterial endotoxin by LAL, and sterility by membrane filtration. Certificates of analysis are issued with full traceability back to API lot, excipient lot, primary-packaging lot and the qualified person responsible for release.

Around those release tests sits a deeper quality architecture: validated water-for-injection generation and looped distribution, qualified HVAC with continuous environmental monitoring, calibrated sterilisation and depyrogenation equipment, validated terminal moist-heat cycles with load mapping, and an electronic batch record system tied into our deviation, change-control and CAPA workflows. Stability is tracked under both long-term (25 °C / 60 % RH) and accelerated (40 °C / 75 % RH) ICH Q1A conditions — Zone IVb included, with photostability testing per ICH Q1B — so we can assure customers the Metoclopramide Injection they buy today will still meet specification when it reaches the patient months later in any climate.

Looking for a sterile injectable manufacturing partner? Submit a Quick Inquiry

Why Farbe Firma is the Trusted Metoclopramide Injection Manufacturer for Global Buyers

Farbe Firma Pvt Ltd manufactures more than 100 sterile injectables across anti-emetic, analgesic, anaesthetic, antibiotic and critical-care categories. For Metoclopramide Injection specifically, we supply the 5 mg/mL ampoule presentation — 10 mg in 2 mL — as standard, with custom strengths, fill volumes and pack configurations available under contract manufacturing agreements. Every batch is released to WHO-GMP standards, with the underlying CTD or ACTD dossier ready to hand for registration in the buyer's target market.

Our CDMO services scale cleanly from hospital pharmacy supply to full national tender procurement. We prepare full eCTD and ACTD modules, drug master files, ICH Q1A and Q1B stability packages, translated package inserts and artwork for Spanish, French, Portuguese, Russian and Arabic markets, and coordinate shipping and logistics to the destination. When a buyer needs Metoclopramide Injection on a tight deadline, our regulatory, manufacturing and logistics teams move as one — dossier, artwork, production slot and shipment plan delivered as a single coordinated package, with a single accountable point of contact.

Buyers stay with Farbe Firma because of audit-readiness and communication. Customer auditors are welcomed onto the plant floor; our quality unit responds to technical queries with primary data, not slogans; and our reviewer team — practising pharmacists and R&D scientists — can talk through formulation, light protection, oxidation control, sterilisation strategy and stability choices in real detail. For a high-volume hospital antiemetic where potency and sterility decide patient outcomes, that openness is exactly what global buyers tell us they value most.

Explore Farbe Firma: Products | Global Reach | About Us

Frequently Asked Questions (FAQ)

Is Farbe Firma a WHO-GMP certified Metoclopramide Injection manufacturer?

Yes. Farbe Firma Pvt Ltd holds WHO-GMP certification and manufactures Metoclopramide Injection at a Gujarat, India facility with ISO Class 5 aseptic processing, qualified ampoule filling lines, qualified water-for-injection systems and validated environmental monitoring. WHO-GMP, USP, BP, IP and EP compliance documentation is available on request.

Which strength and pack size of Metoclopramide Injection do you supply?

Our standard presentation is metoclopramide hydrochloride 5 mg/mL as a clear sterile solution, supplied as 10 mg in a 2 mL single-dose ampoule for intravenous or intramuscular use. Custom strengths, fill volumes, vial formats and multi-pack configurations are available under contract manufacturing agreements — share your specification and our technical team will quote within 48 hours.

Can Farbe Firma support country-specific registrations for Metoclopramide Injection?

Yes. We provide full CTD and ACTD dossier modules, drug master files, ICH Q1A and Q1B stability packages, and translated package inserts and artwork for Spanish, French, Portuguese, Russian and Arabic markets. Our regulatory team has supported registrations across 30+ countries in Africa, LATAM, CIS, GCC, MENA and Southeast Asia.

How does Farbe Firma protect Metoclopramide Injection from light and oxidative degradation?

Metoclopramide is light-sensitive and oxygen-sensitive, so the bulk solution is prepared under nitrogen blanket, ampoules are filled with controlled low-oxygen headspace, and product is handled under light-protected conditions and packaged to shield it from light through to the patient. Photodegradation and oxidative related substances are monitored on every batch by validated stability-indicating HPLC, with photostability confirmed per ICH Q1B.

What is the minimum order quantity for Metoclopramide Injection contract manufacturing?

MOQs vary by strength, label complexity and dossier requirements. For the standard 5 mg/mL ampoule presentation we accommodate hospital-scale and full-tender-scale orders. Contact director@farbefirma.org for a specific quotation against your specification.

Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)

Website: www.farbefirma.org | Email: director@farbefirma.org | Address: Gujarat, INDIA

 
 
 

Comments

Rated 0 out of 5 stars.
No ratings yet

Add a rating
bottom of page